The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials (Q83533299)
Jump to navigation
Jump to search
scientific article published on 07 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials |
scientific article published on 07 March 2011 |
Statements
The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials (English)
J-M Grouin
E Vicaut
S Jean-Alphonse
U Wahn
A Didier
O de Beaumont
A Montagut
M Le Gall